Type I interferon: The ever unfolding story

Current Topics in Microbiology and Immunology

Volumn 316, Issue , 2007, Pages 41-70

  Pitha, P M ^a   Kunzi, M S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CELL RECEPTOR; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; RECOMBINANT INTERFERON;

ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL SPECIFICITY; DRUG MECHANISM; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVIEW; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; SIGNAL TRANSDUCTION;

EID: 38449089229     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-71329-6_4     Document Type: Review

References (171)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801
2. Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti T, Bono M, Ferrantini M, Rozera C, Truini M, Belardelli F, Santi L, Noonan DM (2000) Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach. Am J Pathol 156:1381-1393
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor Nature 413:732-738
4. Angel J, Franco MA, Greenberg HB, Bass D (1999) Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J Interferon Cytokine Res 19:655-659
5. Au WC, Raj NB, Pine R, Pitha PM (1992) Distinct activation of murine interferon-alpha promoter region by IRF-1/ISFG-2 and virus infection. Nucleic Acids Res 20:2877-2884
6. Au WC, Su Y, Raj NB, Pitha PM (1993) Virus-mediated induction of interferon A gene requires cooperation between multiple binding factors in the interferon alpha promoter region. J Biol Chem 268:24032-24040
7. Au WC, Moore PA, Lowther W, Juang YT, Pitha PM (1995) Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 92:11657-11661
8. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM (1998) Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273:29210-29217
9. Au WC, Yeow WS, Pitha PM (2001) Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 280:273-282
10. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA (2004) Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 200:527-533
11. Barnes BJ, Moore PA, Pitha PM (2001) Virus-specific activation of a novel interferon regulatory factor IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276:23382-23390
12. Barnes B, Lubyova B, Pitha PM (2002) On the role of IRF in host defense. J Interferon Cytokine Res 22:59-71
13. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM (2004) Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279:45194-45207
14. Barton GM, Kagan JC, and Medzhitov R (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49-56
15. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711-723
16. Biron CA (2001) Interferons alpha and beta as immune regulators - a new look. Immunity 14:661-664
17. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Ann Rev Immunol 17:189-220
18. Bisat F, Raj NB, Pitha PM (1988) Differential and cell type specific expression of murine alpha-interferon genes is regulated on the transcriptional level. Nucleic Acids Res 16:6067-6083
19. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Haussinger D (2003) IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17:488-490
20. Bogdan C, Mattner J, Schleicher U (2004) The role of type I interferons in non-viral infections. Immunol Rev 202:33-48
21. Bukowski JF, Welsh RM (1985) Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells. J Exp Med 161:257-262
22. Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I (2004) Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol 78:576-584
23. Carrero JA, Calderon B, Unanue ER (2006) Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 203:933-940
24. Carter WA, Pitha PM, Marshall LW, Tazawa I, Tazawa S, Ts'o PO (1972) Structural requirements of the rI n -rC n complex for induction of human interferon. J Mol Biol 70:567-587
25. Cella M, Facchetti F, Lanzavecchia A, Colonna M (2000) Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1:305-310
26. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869
27. Chebath J, Benech P, Revel M, Vigneron M (1987) Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587-588
28. Chehadeh W, Weill J, Vantyghem MC, Alm Gn Lefebvre J, Wattre P, Hober D (2000) Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 181:1929-1939
29. Chen K, Huang J, Zhang C, Huang S, Nunnari G, Wang FX, Tong X, Gao L, Nikisher K, Zhang H (2006) Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol 80:7645-7657
30. Civas A, Genin P, Morin P, Lin R, Hiscott J (2006) Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKK epsilon. J Biol Chem 281:4856-4866
31. Colby C, Chamberlin MJ (1969) The specificity of interferon induction in chick embryo cells by helical RNA. Proc Natl Acad Sci U S A 63:160-167
32. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5:1219-1226
33. Compton T, Kurt-Jones EA, Boehme KW , Belko ELatz J, Golenbock DT, Finberg RW (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77:4588-4596
34. Coro ES, Chang WL, Baumgarth N (2006) Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 176:4343-4351
35. Dai J, Megjugorac NJ, Amrute SB, Fitzgerald-Bocarsly P (2004) Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J Immunol 173:1535-1548
36. Dalgard O, Mangia A (2006) Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infection. Drugs 66:1807-1815
37. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, Biron CA (2003) Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 197:885-898
38. Darnell JE, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
39. De Maeyer-Guignard J, de Maeyer E, Montagnier L (1972) Interferon messenger RNA: translation in heterologous cells. Proc Natl Acad Sci U S A 69:1203-1207
40. De Veer MJ, Holko M,Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR (2001) Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69:912-920
41. Deng C, Goluszko E, Baron S, Wu B, Christadoss P (1996) IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis. J Immunol 157:5675-5682
42. Derynck R, Content J, DeClercq E, Volckaert G, Tavernier J, Devos R, Fiers W (1980a) Isolation and structure of a human fibroblast interferon gene. Nature 285:542-547
43. Derynck R, Remaut E, Saman E, Stanssens P, De Clercq E, Content J, Fiers W (1980b) Expression of human fibroblast interferon gene in Escherichia coli . Nature 287:193-197
44. Devendra D, Eisenbarth GS (2004) Interferon alpha - a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 111:225-233
45. Diaz MO, Pomykala HM, Bohlander SK, Maltepe E, Malik K, Brownstein B, Olopade OI (1994) Structure of the human type-I interferon gene cluster determined from a YAC clone. Genomics 22:540-552
46. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531
47. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T , MacMicking J, Rollinghoff M, Gresser I, Bogdan C (1998) Type 1 interferon (IFN alpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77-87
48. Du W, Thanos D, Maniatis T (1993) Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887-898
49. Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM, Vukmanovic S, Garcia-Sastre A, Levy DE (2000) Type I IFN modulates innate and specific antiviral immunity. J Immunol 164:4220-4228
50. Escalante CR, Yie J, Thanos D, Aggarwal AK (1998) Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391:103-106
51. Espert L, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N (2003) ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 278:16151-16158
52. Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C (2003) Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18:549-558
53. Field AK, Lampson GP, Tytell AA, Nemes MM, Hilleman MR (1967) Inducers of interferon and host resistance. IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage. Proc Natl Acad Sci U S A 58:2102-2108
54. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T (2003) IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496
55. Fitzgerald-Bocarsly P, Feldman M, Mendelsohn M, Curl S, Lopez C (1988) Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J Leukoc Biol 43:323-334
56. Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148
57. Fujita T, Shibuya H, Hotta H, Yamanishi K, Taniguchi T (1987) Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell 49:357-367
58. Gale M Jr, Foy EM (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945
59. Garcia-Sastre A, Biron CA (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879-882
60. Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H (2005) Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol 114:463-471
61. Gold JA, Hoshino Y, Hoshino S, Jones MB, Nolan A, Weiden MD (2004) Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis . Infect Immun 72:1291-1297
62. Goodbourn S, Burstein H, Maniatis T (1986) The human beta-interferon gene enhancer is under negative control. Cell 45:601-610
63. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, Gonzalez Escribano MF, Pons-Estel B, Petri M, Daly M, Gregersen PK, Martin J, Altshuler D, Behrens TW, Alarcon-Riquelme ME (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38:550-555
64. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76:5532-5539
65. Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD, Goeddel DV (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503-508
66. Gresser I, Bourali C, Levy JP, Fontaine-Brouty-Boye D, Thomas MT (1969) Increased survival in mice inoculated with tumor cells and treated with interferon preparations. Proc Natl Acad Sci U S A 63:51-57
67. Hafler DA (2004) Multiple sclerosis. J Clin Invest 113:788-794
68. Hauptmann R, Swetly P (1985) A novel class of human type I interferons. Nucleic Acids Res 13:4739-4749
69. Havell EA, Berman B, Ogburn CA, Berg K, Paucker K, Vilcek J (1975) Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A 72:2185-2187
70. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103
71. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196-200
72. Henco K, Brosius J, Fujisawa A, Fujisawa JI, Haynes JR, Hochstadt J, Kovacic T, Pasek M, Schambock A, Schmid J et al (1985) Structural relationship of human interferon alpha genes and pseudogenes. J Mol Biol 185:227-260
73. Hengel H, Koszinowski UH, Conzelmann KK (2005) Viruses know it all: new insights into IFN networks. Trends Immunol 26:396-401
74. Hilkens CM, Schlaak JF, Kerr IM (2003) Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 171:5255-5263
75. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644-658
76. Honda K, Yanai H, Negishi H, Asagiri M, Sato M et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777
77. Hornung V, Ellegast J, Kim S et al (2006) 5'-Triphosphate RNAIs the Ligand for RIG-I. Science 314:994-997
78. Hu G, Barnes BJ (2006) Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeutics. Expert Rev Anticancer Ther 6:775-784
79. Hueber W, Zeng D, Strober S, Utz PJ (2004) Interferon-alpha-inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum 50:3239-3249
80. Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, Darnell JE Jr (1994) Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc Natl Acad Sci U S A 91:4776-4780
81. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, Feng D, Chung E, Pitha PM, Fitzgerald-Bocarsly P (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74:1125-1138
82. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P (2002) Involvement of plasmacytoid dendritic cells in human diseases. Hum Immunol 63:1201-1205
83. Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A 95:9837-9842
84. Karp CL, Biron CA, Irani DN (2000) Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today 21:24-28
85. Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105
86. Kelley KA, Kozak CA, Pitha PM (1985) Localization of the mouse interferon-beta gene to chromosome 4. J Interferon Res 5:409-413
87. Kelley KA, Pitha PM (1985a) Characterization of a mouse interferon gene locus I. Isolation of a cluster of four alpha interferon genes. Nucleic Acids Res 13:805-823
88. Kelley KA, Pitha PM (1985b) Characterization of a mouse interferon gene locus II. Differential expression of alpha-interferon genes. Nucleic Acids Res 13:825-839
89. Kerr IM, Brown RE (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A 75:256-260
90. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77
91. Kraus TA, Lau JF, Parisien JP, Horvath CM (2003) A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response. J Biol Chem 278:13033-13038
92. Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH (2006) Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr 41:149-153
93. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M (2004) Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103:1433-1437
94. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A 91:6288-6292
95. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401
96. LaFleur DW, Nardelli B, Tsareva T et al (2001) Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem 276:39765-39771
97. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14:432-436
98. Lee J, Wu CC, Lee KJ et al (2006) Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A 103:1828-1833
99. Lee YF, Nomoto A, Detjen BM, and Wimmer E (1977) A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A 74:59-63
100. Lin R, Mamane Y, Hiscott J (1999) Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19:2465-2474
101. Long WF, Burke DC (1971) Interferon production by double-stranded RNA: a comparison of induction by reovirus to that by a synthetic double-stranded polynucleotide. J Gen Virol 12:1-11
102. Lopez S, Island ML, Drouin J et al (2000) Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx 1. Mol Cell Biol 20:7527-7540
103. Lund J, Sato A, Akira S , Medzhitov R, Iwasaki A (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198:513-520
104. Lund JM, Alexopoulou L, Sato A et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101:5598-5603
105. MacDonald NJ, Kuhl D, Maguire D et al (1990) Different pathways mediate virus inducibility of the human IFN-alpha 1 and IFN-beta genes. Cell 60:767-779
106. Mancl ME, Hu G, Sangster-Guity N et al (2005) Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 280:21078-21090
107. Marchisone C, Benelli R, Albini A, Santi L, Noonan DM (1999) Inhibition of angiogenesis by type I interferons in models of Kaposi's sarcoma. Int J Biol Markers 14:257-262
108. Marie I, Durbin JE, Levy DE (1998) Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 17:6660-6669
109. Marrack P, JKappler, and TMitchell (1999) Type I interferons keep activated T cells alive. JExp Med 189:521-30
110. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T (2004) IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101:233-238
111. Megyeri K, Au WC, Rosztoczy I, Raj NB, Miller RL, Tomai MA, Pitha PM (1995) Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol 15:2207-2218
112. Melchjorsen J, Jensen SB , Malmgaard L et al (2005) Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79:12944-12951
113. Merika M, Williams AJ, Chen G, Collins T, Thanos D (1998) Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1:277-287
114. Miyamoto M, Fujita T, Kimura Y et al (1988) Regulated expression of a gene encoding a nuclear factor IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54:903-913
115. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H (2002) Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21:2914-2918
116. Morin P, Braganca J, Bandu MT, Lin R, Hiscott J, Doly J, Civas A (2002) Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J Mol Biol 316:1009-1022
117. Moustakas A, Heldin CH (2003) The nuts and bolts of IRF structure. Nat Struct Biol 10:874-876
118. Murphy DG, Dimock K, Kang CY (1991) Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 181:760-763
119. Nagata S, Mantei N, Weissmann C (1980) The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 287:401-408
120. Negishi H, Ohba Y, Yanai H et al (2005) Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci U S A 102:15989-15994
121. O'Connell RM, Vaidya SA, Perry AK, Saha SK, Dempsey PW, Cheng G (2005) Immune activation of type IIFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J Immunol 174:1602-1607
122. O'Neill LA (2006) How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18:3-9
123. Ortaldo JR, Herberman RB, Harvey C, Osheroff P, Pan YC, Kelder B, Pestka S (1984) A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A 81:4926-4929
124. Ousman SS, Wang J, Campbell IL (2005) Differential regulation of interferon regulatory factor IRF-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 79:7514-7527
125. Paucker K, Cantell K (1962) Neutralization of interferon by specific antibody. Virology 18:145-147
126. Penna G, Vulcano M, Sozzani S, Adorini L (2002) Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63:1164-1171
127. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001
128. Pitha J, Pitha PM (1971) Antiviral resistance by the polyinosinic acid-poly (1-vinylcytosine) complex. Science 172:1146-1148
129. Pitha PM, Carter WA (1971) Antiviral activity produced by the polycytidylic acid-hexainosinate system. Nat New Biol 234:105-106
130. Pitha PM, Pitha J (1972) Nonenzymatic synthesis of oligoadenylates on template lacking steric regularity. Nat New Biol 240:78-80
131. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375-386
132. Prakash A, Smith E, Lee CK, Levy DE (2005) Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280:18651-18657
133. Reynolds FH Jr, Pitha PM (1974) The induction of interferon and its messenger RNA in human fibroblasts. Biochem Biophys Res Commun 59:1023-1030
134. Reynolds FH Jr, Premkumar E, Pitha PM (1975) Interferon activity produced by translation of human interferon messenger RNA in cell-free ribosomal systems and in Xenopus oocytes. Proc Natl Acad Sci U S A 72:4881-4885
135. Ruffner H, Reis LF, Naf D, Weissmann C (1993) Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci U S A 90:11503-11507
136. Samuel CE (1979) Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A 76:600-604
137. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778-809
138. Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, Belardelli F (2000) Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191:1777-1788
139. Sareneva T, Matikainen S, Kurimoto M,Julkunen I (1998) Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 160:6032-6038
140. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K et al (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548
141. Schiavoni G, Mauri C, Carlei D, Belardelli F, Pastoris MC, Proietti E (2004) Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway. J Immunol 173:1266-1275
142. Schoenemeyer A, Barnes BJ, Mancl ME et al (2005) The interferon regulatory factor IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 280:17005-17012
143. Schultz R, Williams C (2005) Developmental biology: sperm-egg fusion unscrambled. Nature 434:152-153
144. Sekellick MJ, Marcus PI (1982) Interferon induction by viruses. VIII. Vesicular stomatitis virus:±DI-011 particles induce interferon in the absence of standard virions. Virology 117:280-285
145. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151
146. Sheppard P, Kindsvogel W, Xu W et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68
147. Siegal FP, Kadowaki N, Shodell M et al (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835-1837
148. Slade HB, Owens ML, Tomai MA, Miller RL (1998) Imiquimod 5% cream (Aldara). Expert Opin Investig Drugs 7:437-449
149. Sobel DO, Ahvazi B (1998) Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes 47:1867-1872
150. Stetson DB, Medzhitov R (2006) Type I interferons in host defense. Immunity 25:373-381
151. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ (1993) Induction of type I diabetes by interferon-alpha in transgenic mice. Science 260:1942-1946
152. Stojdl DF, Abraham N, Knowles S et al (2000) The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74:9580-9585
153. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase RIG-I. J Virol 79:2689-2699
154. Takaoka A, Yanai H, Kondo S et al (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249
155. Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O'Shea JJ, Singh H, Ozato K (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 174:2573-2581
156. Thanos D, Maniatis T (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100
157. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336
158. Wagner RR (1964) Inhibition of interferon biosynthesis by actinomycin D. Nature 204:49-51
159. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373
160. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1:507-518
161. Weaver BK, Kumar KP, Reich NC (1998) Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF. Mol Cell Biol 18:1359-1368
162. Weidle U, Weissmann C (1983) The 5?-flanking region of a human IFN-alpha gene mediates viral induction of transcription. Nature 303:442-446
163. Weigent DA, Huff TL, Peterson JW, Stanton GJ, Baron S (1986) Role of interferon in streptococcal infection in the mouse. Microb Pathog 1:399-407
164. Weissmann C, Weber H (1986) The interferon genes. Prog Nucleic Acid Res Mol Biol 33:251-300
165. Wheelock EF, Sibley WA (1965) Circulating virus interferon and antibody after vaccination with the 17-D strain of yellow-fever virus. N Engl J Med 273:194-198
166. Yeow WS, Au WC, Juang YT, Fields CD, Dent CL, Gewert DR, Pitha PM (2000) Reconstitution of virus-mediated expression of interferon alpha genes in human fibroblast cells by ectopic interferon regulatory factor-1. J Biol Chem 275:6313-6320
167. Yoneyama M, Suhara W, Fukuhara Y et al (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p3. EMBO J 17:1087-1095
168. Yoneyama M, Kikuchi M, Natsukawa T et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737
169. Yu X, Yu Y, Liu B et al (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060
170. Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-1. Immunity 8:591-599
171. Zwarthoff EC, Mooren AT, Trapman J (1985) Organization, structure and expression of murine interferon alpha genes. Nucleic Acids Res 13:791-804